Filing Details
- Accession Number:
- 0000899243-22-018605
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-18 16:22:39
- Reporting Period:
- 2022-05-16
- Accepted Time:
- 2022-05-18 16:22:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-16 | 7 | $250.56 | 41,787 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-16 | 8 | $251.37 | 41,779 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-16 | 7 | $252.43 | 41,772 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-16 | 15 | $253.99 | 41,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-16 | 8 | $254.44 | 41,749 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
- Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87).
- Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88).
- Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07).
- Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32).
- Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57).
Billionaire Hedge Funds
